F Aversa

Summary

Affiliation: University of Perugia
Country: Italy

Publications

  1. ncbi Transplants across human leukocyte antigen barriers
    Massimo F Martelli
    Department of Hematology, University of Perugia, Perugia, Italy
    Semin Hematol 39:48-56. 2002
  2. ncbi Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation
    Loredana Ruggeri
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Policlinico Monteluce, Via Brunamonti 51, Perugia, Italy
    Semin Cancer Biol 16:404-11. 2006
  3. ncbi Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
    Loredana Ruggeri
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Italy
    Immunol Rev 214:202-18. 2006
  4. ncbi Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation
    Katia Perruccio
    Department of Clinical and Experimental Medicine, IRCCS Foundation on Transplantation Biotechnologies, University of Perugia, Via Brunamonti 51, 06123, Italy
    Blood Cells Mol Dis 40:76-83. 2008
  5. doi A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
    Fabio Ciceri
    Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy
    Blood 112:3574-81. 2008
  6. pmc T cell depleted haploidentical transplantation: positive selection
    Franco Aversa
    Pediatric Oncology Hematology, BMT Unit, Section of Hematology, Department of Internal and Experimental Medicine, University of Perugia, Perugia, Italy
    Pediatr Rep 3:e14. 2011
  7. ncbi Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia
    F Aversa
    BMT Program, Section of Hematology and Clinical Immunology, University of Perugia, Italy
    J Clin Oncol 17:1545-50. 1999
  8. ncbi Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004
    Franco Aversa
    Department of Clinical and Experimental Medicine, University of Perugia, Italy
    Blood Cells Mol Dis 33:159-75. 2004
  9. ncbi Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse
    Franco Aversa
    HSCT Unit, Hematology Section, Department of Clinical and Experimental Medicine, University of Perugia, 06100 Perugia, Italy
    J Clin Oncol 23:3447-54. 2005
  10. ncbi Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases
    Franco Aversa
    Hematology and Clinical Immunology Section, Department of Clinical and Experimental Medicine, University of Perugia, Via Brunamonti, 06123 Perugia, Italy
    Springer Semin Immunopathol 26:155-68. 2004

Collaborators

Detail Information

Publications56

  1. ncbi Transplants across human leukocyte antigen barriers
    Massimo F Martelli
    Department of Hematology, University of Perugia, Perugia, Italy
    Semin Hematol 39:48-56. 2002
    ..T-cell-depleted megadose stem cell transplant from a mismatched family member, who is immediately available, can now be offered as a viable option to candidates with high-risk acute leukemias...
  2. ncbi Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation
    Loredana Ruggeri
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Policlinico Monteluce, Via Brunamonti 51, Perugia, Italy
    Semin Cancer Biol 16:404-11. 2006
    ..In clinical trials, donor versus recipient NK alloreactions are highly beneficial as they reduce the risk of leukemia relapse, do not cause GvHD and markedly improve event-free survival...
  3. ncbi Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
    Loredana Ruggeri
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Italy
    Immunol Rev 214:202-18. 2006
    ..We review the translation of NK cell recognition of missing self into the clinical practice of allogeneic hematopoietic transplantation and discuss how it has opened innovative perspectives in the cure of leukemia...
  4. ncbi Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation
    Katia Perruccio
    Department of Clinical and Experimental Medicine, IRCCS Foundation on Transplantation Biotechnologies, University of Perugia, Via Brunamonti 51, 06123, Italy
    Blood Cells Mol Dis 40:76-83. 2008
    ..Consequently, a clinical trial is planned to incorporate infusion of photo-allodepleted donor T cells after haploidentical stem cell transplantation with the aim of decreasing infection-related mortality...
  5. doi A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
    Fabio Ciceri
    Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy
    Blood 112:3574-81. 2008
    ..In conclusion, haplo-HSCT can be an alternative option for the treatment of high-risk acute leukemia patients in remission, lacking a human leukocyte antigen-matched donor...
  6. pmc T cell depleted haploidentical transplantation: positive selection
    Franco Aversa
    Pediatric Oncology Hematology, BMT Unit, Section of Hematology, Department of Internal and Experimental Medicine, University of Perugia, Perugia, Italy
    Pediatr Rep 3:e14. 2011
    ..Overall, event-free survival and transplant-related mortality compare favourably with reports on transplants from sources of stem cells other than the matched sibling...
  7. ncbi Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia
    F Aversa
    BMT Program, Section of Hematology and Clinical Immunology, University of Perugia, Italy
    J Clin Oncol 17:1545-50. 1999
    ..To eliminate the risk of rejection and lower the risk of relapse after T-cell-depleted bone marrow transplants in acute leukemia patients, we enhanced pretransplant immunosuppression and myeloablation...
  8. ncbi Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004
    Franco Aversa
    Department of Clinical and Experimental Medicine, University of Perugia, Italy
    Blood Cells Mol Dis 33:159-75. 2004
    ..The Workshop closed with presentations on tolerance induction that was followed by the results of ongoing registration studies being performed by the Italian GIMEMA group and the European Bone Marrow Transplant group...
  9. ncbi Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse
    Franco Aversa
    HSCT Unit, Hematology Section, Department of Clinical and Experimental Medicine, University of Perugia, 06100 Perugia, Italy
    J Clin Oncol 23:3447-54. 2005
    ..As our original method of graft processing was unsuitable for large-scale clinical studies, we use automated devices for CD34+ cell purification...
  10. ncbi Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases
    Franco Aversa
    Hematology and Clinical Immunology Section, Department of Clinical and Experimental Medicine, University of Perugia, Via Brunamonti, 06123 Perugia, Italy
    Springer Semin Immunopathol 26:155-68. 2004
    ....
  11. ncbi The haploidentical option for high-risk haematological malignancies
    Franco Aversa
    Department of Hematology, University of Perugia, Italy
    Blood Cells Mol Dis 40:8-12. 2008
    ....
  12. doi Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States
    F Aversa
    Haematopoietic Stem Cell Transplant Unit, Section of Haematology and Immunology, IBiT Foundation, University of Perugia, Perugia, Italy
    Bone Marrow Transplant 41:473-81. 2008
    ..Improvements will come with successful implementation of strategies to accelerate and strengthen post transplant immune reconstitution as well as transplantation of patients in early stage disease...
  13. ncbi Full haplotype mismatched hematopoietic stem cell transplants
    Franco Aversa
    Hematopoietic Stem Cell Transplantation Program, Section of Hematology, Department of Internal and Experimental Medicine, University of Perugia, Italy
    Haematologica 87:9-12. 2002
    ....
  14. ncbi Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option
    Franco Aversa
    Hematopoietic Stem Cell Transplant Unit, Section of Hematology and Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia 06100, Italy
    Curr Stem Cell Res Ther 2:105-12. 2007
    ....
  15. ncbi Hematopoietic stem cell transplantation from full-haplotype mismatched donors
    Franco Aversa
    Section of Hematology and Clinical Immunology, Centro Trapianti Midollo Osseo, Policlinico Monteluce, Universita di Perugia, Italy
    Transfus Apher Sci 27:175-81. 2002
    ..Event-free survival and transplant-related mortality for high risk acute leukemia patients treated at less advanced stages of disease compare favourably with reports from unrelated matched transplants...
  16. doi Setting the standard in T-cell-depleted haploidentical transplantation and beyond
    Franco Aversa
    Pediatric Oncology Hematology and BMT Unit, Section of Hematology, Department of Internal and Experimental Medicine, University of Perugia, Perugia, Italy
    Best Pract Res Clin Haematol 24:325-9. 2011
    ..The present challenge is to reduce post-transplant infectious mortality and several strategies are being tested...
  17. ncbi Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia
    Franco Aversa
    Department of Hematology, University of Perugia, Perugia, Italy
    Blood Cells Mol Dis 33:294-302. 2004
    ..T-cell-depleted megadose stem cell transplant from a mismatched family member, who is immediately available, can be offered as a viable option to candidates with high-risk acute leukemias...
  18. ncbi Allogeneic transplantation across the HLA barriers
    F Aversa
    Hematopoietic Stem Cell Transplant Program, Section of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
    Rev Clin Exp Hematol 5:147-61. 2001
    ....
  19. ncbi Haploidentical stem cell transplantation in leukemia
    F Aversa
    Hematopoietic Stem Cell Program, Department of Clinical and Experimental Medicine, Section of Hematology and Clinical Immunology, University of Perugia, Perugia, 06100, Italy
    Blood Rev 15:111-9. 2001
    ....
  20. ncbi Haploidentical stem cell transplantation for acute leukemia
    F Aversa
    Department of Internal and Experimental Medicine, University of Perugia, Italy
    Int J Hematol 76:165-8. 2002
    ..In conclusion, given our current results, the most suitable candidate for the full haplotype mismatched transplant should be in early stage disease and selection of an NK alloreactive donor is recommended...
  21. ncbi Total body irradiation-based regimen in the conditioning of patients submitted to haploidentical stem cell transplantation
    C Aristei
    Institute of Radiotherapy Oncology, General Hospital and University, Perugia, Italy
    Radiother Oncol 58:247-9. 2001
    ..25+/-0.09 for acute myeloid leukaemia and 0.17+/-0.07 for acute lymphoid leukaemia patients. CONCLUSIONS: This study shows that the main obstacles limiting the use of mismatched transplants, i.e. GvHD and rejection, were overcome...
  22. ncbi Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants
    I Volpi
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Italy
    Blood 97:2514-21. 2001
    ..Elimination of postgrafting administration of G-CSF prevented immune dysregulation and accelerated functional immune recovery...
  23. ncbi Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
    Loredana Ruggeri
    Department of Clinical and Experimental Medicine, Section of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy
    Science 295:2097-100. 2002
    ..NK cell alloreactivity may thus provide a powerful tool for enhancing the efficacy and safety of allogeneic hematopoietic transplantation...
  24. ncbi Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT
    K Perruccio
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
    Bone Marrow Transplant 47:1196-200. 2012
    ..This study demonstrated that LDA is a reliable, predictable and sensitive method for measuring alloreactive, pathogen- and leukemia-specific T-cell frequencies...
  25. ncbi Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation
    L Ruggeri
    Division of Haematology and Clinical Immunology, University of Perugia, Italy
    Cytotherapy 8:554-8. 2006
    ..The infusion of alloreactive NK cells ablates (i) leukemic cells, (ii) recipient T cells that reject the graft and (iii) recipient DC that trigger GvHD, thus protecting from GvHD...
  26. ncbi Innate immunity against hematological malignancies
    L Ruggeri
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Italy
    Cytotherapy 4:343-6. 2002
    ..Natural killer (NK) cells are negatively regulated by MHC Class I-specific inhibitory receptors. Mismatched transplants may therefore trigger NK-cell alloreactivity...
  27. doi Natural killer-cell KIR repertoire reconstitution after haploidentical SCT
    M Stern
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
    Bone Marrow Transplant 45:1607-10. 2010
    ..In conclusion, we show that the kinetics with which single KIR-expressing NK cells are generated after haploidentical SCT differ between individual KIR receptors and seem to influence survival after haploidentical SCT...
  28. ncbi Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation
    C Aristei
    Institute of Radiotherapy Oncology, General Hospital and Perugia University, Policlinico Monteluce, 06122 Perugia, Italy
    Bone Marrow Transplant 29:503-7. 2002
    ..T cell depletion, because it prevents graft-versus-host disease and reduces the protracted use of post-transplant steroids, explains the results we obtained...
  29. pmc Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value
    Loredana Ruggeri
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Istituto di Ricovero e Cura a Carattere Scientifico, Foundation on Transplantation Biotechnologies, Perugia, Italy
    Blood 110:433-40. 2007
    ..Only transplantation from NK-alloreactive donors is associated with a survival advantage...
  30. ncbi Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation
    Andrea Velardi
    Division of Hematology and Clinical Immunology, Perugia, Italy
    Hematol J 5:S87-90. 2004
  31. doi In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study
    C Aristei
    Radiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy
    Bone Marrow Transplant 48:908-14. 2013
    ..Most Centres adopted a hyperfractionated schedule that is used worldwide (12 Gy in six fractions over 3 days), which appears to have become standard. TBI doses impacted significantly upon relapse rates...
  32. doi Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation
    A Carvalho
    Division of Microbiology, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, Perugia, Italy
    Bone Marrow Transplant 45:1645-52. 2010
    ..Although validation studies are ultimately required, our results would suggest the potential usefulness of IL-23/Th17 genotyping in donor selection and patient evaluation...
  33. doi Regression modeling of competing risk using R: an in depth guide for clinicians
    L Scrucca
    Statistics Section, Department of Economy Finance and Statistics, University of Perugia, Perugia, Italy
    Bone Marrow Transplant 45:1388-95. 2010
    ..J Am Stat Assoc 1999; 94: 496-509...
  34. ncbi Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation
    Loredana Ruggeri
    Department of Clinical and Experimental Medicine, Haematology and Clinical Immunology, University of Perugia, Italy
    Blood Cells Mol Dis 33:216-21. 2004
    ..recipient NK alloreactions...
  35. ncbi Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor
    C Carlo-Stella
    Department of Hematology, University of Parma, Italy
    Exp Hematol 28:216-24. 2000
    ....
  36. ncbi Competing risk analysis using R: an easy guide for clinicians
    L Scrucca
    Statistics Section, Department of Economy Finance and Statistics, University of Perugia, Perugia, Italy
    Bone Marrow Transplant 40:381-7. 2007
    ..We provide all the instructions for downloading it from internet and illustrate how to use it for analysis of a sample dataset of patients who underwent haematopoietic stem cell transplantation for acute leukaemia...
  37. ncbi Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation
    Andrea Velardi
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy
    Semin Immunopathol 30:489-503. 2008
    ..Here, we review the translation of NK cell allorecognition into the clinical practice of allogeneic hematopoietic transplantation and discuss how it has opened innovative perspectives in the cure of leukemia...
  38. ncbi Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia
    Andrea Velardi
    Division of Haematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Ospedale Santa Maria della Misericordia, 06132 Perugia, Italy
    Curr Opin Immunol 21:525-30. 2009
    ..Studies have been performed to infuse NK cells for immunotherapy outside the fields of transplantation and/or harness the function of endogenous NK cells in patients with hematological malignancies...
  39. ncbi Natural killer cell alloreactivity in allogeneic hematopoietic transplantation
    Loredana Ruggeri
    Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
    Curr Opin Oncol 19:142-7. 2007
    ..Mismatched transplantation, however, triggers alloreactivity mediated by natural killer cells which is based upon 'missing self recognition'...
  40. ncbi Natural killer cells as a therapeutic tool in mismatched transplantation
    Loredana Ruggeri
    Division of Haematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Policlinico Monteluce, Via Brunamonti 06100, Perugia, Italy
    Best Pract Res Clin Haematol 17:427-38. 2004
    ....
  41. ncbi Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004
    Daniela Francisci
    Division of Infectious Diseases, Department of Experimental Medicine and Biochemical Science, University of Perugia, Ospedale R Silvestrini, Sant Andrea delle Fratte, 06156, Perugia, Italy
    Haematologica 91:980-2. 2006
    ..HBV and HBC did not affect the outcome of T-cell depleted hematopoieic stem cell transplantation. Surveillance is important given the risk of HCV and HBV infection and/or reactivation and the efficacy of the new anti-hepatitis drugs...
  42. ncbi Graft engineering for allogeneic haploidentical stem cell transplantation
    Antonio Tabilio
    Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
    Blood Cells Mol Dis 33:274-80. 2004
    ..Modern time-saving automated graft processing devices ensure reproducibility, reliability, and biological safety, which make widespread application of the haploidentical transplant currently feasible...
  43. ncbi NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation
    Loredana Ruggeri
    Department of Clinical and Experimental Medicine, IRCCS Foundation on Transplantation Biotechnologies, University of Perugia, Italy
    Blood Cells Mol Dis 40:84-90. 2008
    ..We are designing a clinical haploidentical transplant trial using alloreactive NK cells in the conditioning regimen, with the aim of reducing TRM and improving outcomes and overall survival...
  44. ncbi Large-scale generation of human allodepleted anti-3rd party lymphocytes
    Maria De Ioanni
    Department of Clinical and Experimental Medicine, IRCCS Foundation on Transplantation Biotechnologies, University of Perugia, Italy
    Blood Cells Mol Dis 40:106-12. 2008
    ..These anti-3rd party lymphocytes contain a large adaptive T regulatory cell subset which might contribute to in vitro and in vivo immune modulation...
  45. pmc Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
    Katia Perruccio
    Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Policlinico Monteluce, Via Brunamonti 51 06122 Perugia, Italy
    Blood 106:4397-406. 2005
    ..This study opens new perspectives for reducing infectious mortality after haploidentical transplantations...
  46. ncbi Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation
    Katia Perruccio
    Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
    Ann N Y Acad Sci 1194:153-61. 2010
    ..Larger numbers of patients and longer follow-up are, of course, needed to assess its impact on survival...
  47. pmc The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
    A Carvalho
    Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Braga, Portugal
    Genes Immun 13:197-201. 2012
    ..Moreover, the increased transcriptional activity of TLR9 in mononuclear cells from patients harboring rs5743836 further supports a functional effect of this polymorphism on NHL susceptibility in a population-dependent manner...
  48. doi Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation
    Agostinho Carvalho
    Microbiology, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy
    Exp Hematol 37:1022-9. 2009
    ..Discovery of genetic variations in the genes encoding for Toll-like receptors (TLRs) has highlighted a potential link between genomic variation of the host and susceptibility to infections...
  49. doi Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
    Corrado Girmenia
    Department of Hematology, Policlinico Umberto I, University of Sapienza, Rome, Italy
    Clin Infect Dis 49:1226-36. 2009
    ....
  50. ncbi Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation
    Claudia Montagnoli
    Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy
    Blood Cells Mol Dis 40:55-62. 2008
    ..Thus, transplantation tolerance and concomitant pathogen clearance could be achieved through the therapeutic induction of antigen-specific Treg cells via instructive immunotherapy with pathogen- or TLR-conditioned donor DC...
  51. ncbi Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation
    Katia Perruccio
    Division of Hematology, Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
    Blood Cells Mol Dis 33:248-55. 2004
    ..Thus, the remarkable functional plasticity of DCs in response to fungi can be exploited for the deliberate targeting of cells and pathways of cell-mediated immunity in response to fungal vaccines...
  52. ncbi Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia
    Roberto Rosati
    Hematology and Bone Marrow Transplantation Unit, University of Perugia, Policlinico Monteluce, Via Brunamonti 51, 06122 Perugia, Italy
    Haematologica 92:232-5. 2007
    ..We set up molecular assays to monitor the chimeric TAF-Ialpha/CAN and TAF-Ibeta/CAN transcripts which, after hematopoietic stem cell transplantation from an HLA-identical sibling, were no longer detected...
  53. ncbi Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
    Morena Caira
    Eur J Haematol 81:242-3. 2008
  54. ncbi Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma
    Arcangelo Liso
    University of Foggia, Italy
    Lancet Oncol 5:127-8. 2004
  55. pmc Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor
    Martin Stern
    Department of Hematology, University Hospital Basel, Basel, Switzerland
    Blood 112:2990-5. 2008
    ..Although obtained in a retrospective analysis, these data suggest that the mother of the patient should be preferred as donor for haploidentical HSCT...
  56. ncbi The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study
    Livio Pagano
    Istituto di Ematologi, Universita Cattolica del Sacro Cuore, Largo Francesco Vito, 1, I 00168 Rome, Italy
    Haematologica 91:1068-75. 2006
    ..The aim of this study was to evaluate the incidence and outcome of invasive fungal infections (IFI) in patients with hematologic malignancies...